Literature DB >> 21606290

Dual-energy dual-source CT with additional spectral filtration can improve the differentiation of non-uric acid renal stones: an ex vivo phantom study.

Mingliang Qu1, Juan C Ramirez-Giraldo, Shuai Leng, James C Williams, Terri J Vrtiska, John C Lieske, Cynthia H McCollough.   

Abstract

OBJECTIVE: The purpose of this study was to determine the ex vivo ability of dual-energy dual-source CT (DSCT) with additional tin filtration to differentiate among five groups of human renal stone types.
MATERIALS AND METHODS: Forty-three renal stones of 10 types were categorized into five primary groups on the basis of effective atomic numbers, which were calculated as the weighted average of the atomic numbers of constituent atoms. Stones were embedded in porcine kidneys and placed in a 35-cm water phantom. Dual-energy DSCT scans were performed at 80 and 140 kV with and without tin filtration of the 140-kV beam. The CT number ratio, defined as the ratio of the CT number of a given material in the low-energy image to the CT number of the same material in the high-energy image, was calculated on a volumetric voxel-by-voxel basis for each stone. Statistical analysis was performed, and receiver operating characteristic (ROC) curves were plotted to compare the difference in CT number ratio with and without tin filtration, and to measure the discrimination among stone groups.
RESULTS: The CT number ratio of non-uric acid stones increased on average by 0.17 (range, 0.03-0.36) with tin filtration. The CT number ratios for non-uric acid stone groups were not significantly different (p > 0.05) between any of the two adjacent groups without tin filtration. Use of the additional tin filtration on the high-energy x-ray tube significantly improved the separation of non-uric acid stone types by CT number ratio (p < 0.05). The area under the ROC curve increased from 0.78 to 0.84 without fin filtration and to 0.89-0.95 with tin filtration.
CONCLUSION: Our results showed better separation among different stone types when additional tin filtration was used on dual-energy DSCT. The increased spectral separation allowed a five-group stone classification scheme. Some overlapping between particular stone types still exists, including brushite and calcium oxalate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21606290      PMCID: PMC3901037          DOI: 10.2214/AJR.10.5041

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  32 in total

Review 1.  Pathophysiology and management of infectious staghorn calculi.

Authors:  Kelly A Healy; Kenneth Ogan
Journal:  Urol Clin North Am       Date:  2007-08       Impact factor: 2.241

2.  Material differentiation by dual energy CT: initial experience.

Authors:  Thorsten R C Johnson; Bernhard Krauss; Martin Sedlmair; Michael Grasruck; Herbert Bruder; Dominik Morhard; Christian Fink; Sabine Weckbach; Miriam Lenhard; Bernhard Schmidt; Thomas Flohr; Maximilian F Reiser; Christoph R Becker
Journal:  Eur Radiol       Date:  2006-12-07       Impact factor: 5.315

3.  First performance evaluation of a dual-source CT (DSCT) system.

Authors:  Thomas G Flohr; Cynthia H McCollough; Herbert Bruder; Martin Petersilka; Klaus Gruber; Christoph Süss; Michael Grasruck; Karl Stierstorfer; Bernhard Krauss; Rainer Raupach; Andrew N Primak; Axel Küttner; Stefan Achenbach; Christoph Becker; Andreas Kopp; Bernd M Ohnesorge
Journal:  Eur Radiol       Date:  2005-12-10       Impact factor: 5.315

Review 4.  Kidney stones: pathophysiology and medical management.

Authors:  Orson W Moe
Journal:  Lancet       Date:  2006-01-28       Impact factor: 79.321

5.  Characterization of human renal stones with MDCT: advantage of dual energy and limitations due to respiratory motion.

Authors:  Romain Grosjean; Benoît Sauer; Rui Matias Guerra; Michel Daudon; Alain Blum; Jacques Felblinger; Jacques Hubert
Journal:  AJR Am J Roentgenol       Date:  2008-03       Impact factor: 3.959

6.  Noninvasive differentiation of uric acid versus non-uric acid kidney stones using dual-energy CT.

Authors:  Andrew N Primak; Joel G Fletcher; Terri J Vrtiska; Oleksandr P Dzyubak; John C Lieske; Molly E Jackson; James C Williams; Cynthia H McCollough
Journal:  Acad Radiol       Date:  2007-12       Impact factor: 3.173

7.  Dual source computed tomography: a novel technique to determine stone composition.

Authors:  Brian R Matlaga; Satomi Kawamoto; Elliot Fishman
Journal:  Urology       Date:  2008-07-10       Impact factor: 2.649

8.  Dual-energy computed tomography for the differentiation of uric acid stones: ex vivo performance evaluation.

Authors:  Paul Stolzmann; Hans Scheffel; Katharina Rentsch; Thomas Schertler; Thomas Frauenfelder; Sebastian Leschka; Tullio Sulser; Borut Marincek; Hatem Alkadhi
Journal:  Urol Res       Date:  2008-06-11

9.  Dual energy CT characterization of urinary calculi: initial in vitro and clinical experience.

Authors:  Anno Graser; Thorsten R C Johnson; Markus Bader; Michael Staehler; Nicolas Haseke; Konstantin Nikolaou; Maximilian F Reiser; Christian G Stief; Christoph R Becker
Journal:  Invest Radiol       Date:  2008-02       Impact factor: 6.016

10.  Renal stone assessment with dual-energy multidetector CT and advanced postprocessing techniques: improved characterization of renal stone composition--pilot study.

Authors:  Daniel T Boll; Neil A Patil; Erik K Paulson; Elmar M Merkle; W Neal Simmons; Sean A Pierre; Glenn M Preminger
Journal:  Radiology       Date:  2009-03       Impact factor: 11.105

View more
  38 in total

Review 1.  Dual-energy computed tomography applications in uroradiology.

Authors:  Jong Park; Hersh Chandarana; Michael Macari; Alec J Megibow
Journal:  Curr Urol Rep       Date:  2012-02       Impact factor: 3.092

2.  Evaluation of low-dose dual energy computed tomography for in vivo assessment of renal/ureteric calculus composition.

Authors:  Harshavardhan Mahalingam; Anupam Lal; Arup K Mandal; Shrawan Kumar Singh; Shalmoli Bhattacharyya; Niranjan Khandelwal
Journal:  Korean J Urol       Date:  2015-08-10

Review 3.  [Urolithiasis 2016 : Reliable, effective and low radiation exposure].

Authors:  A Neisius; C Thomas; F C Roos; W Jäger; I Tsaur; G Bartsch; T Knoll; A Haferkamp
Journal:  Urologe A       Date:  2016-10       Impact factor: 0.639

4.  Differentiating calcium oxalate and hydroxyapatite stones in vivo using dual-energy CT and urine supersaturation and pH values.

Authors:  Yu Liu; Mingliang Qu; Rickey E Carter; Shuai Leng; Juan Carlos Ramirez-Giraldo; Giselle Jaramillo; Amy E Krambeck; John C Lieske; Terri J Vrtiska; Cynthia H McCollough
Journal:  Acad Radiol       Date:  2013-12       Impact factor: 3.173

5.  [Imaging for diagnostics of urolithiasis including dual-energy CT].

Authors:  F Strittmatter; C Gratzke; A Graser; C G Stief; T R C Johnson
Journal:  Urologe A       Date:  2013-04       Impact factor: 0.639

6.  Fragility of brushite stones in shock wave lithotripsy: absence of correlation with computerized tomography visible structure.

Authors:  James C Williams; Tariq Hameed; Molly E Jackson; Syed Aftab; Alessia Gambaro; Yuri A Pishchalnikov; James E Lingeman; James A McAteer
Journal:  J Urol       Date:  2012-07-21       Impact factor: 7.450

7.  Micro-CT imaging of Randall's plaques.

Authors:  James C Williams; James E Lingeman; Fredric L Coe; Elaine M Worcester; Andrew P Evan
Journal:  Urolithiasis       Date:  2014-08-06       Impact factor: 3.436

Review 8.  An overview of kidney stone imaging techniques.

Authors:  Wayne Brisbane; Michael R Bailey; Mathew D Sorensen
Journal:  Nat Rev Urol       Date:  2016-08-31       Impact factor: 14.432

Review 9.  Lifetime Radiation Exposure in Patients with Recurrent Nephrolithiasis.

Authors:  Mohamed A Elkoushy; Sero Andonian
Journal:  Curr Urol Rep       Date:  2017-09-12       Impact factor: 3.092

10.  Robustness of Textural Features to Predict Stone Fragility Across Computed Tomography Acquisition and Reconstruction Parameters.

Authors:  Taylor Moen; Andrea Ferrero; Cynthia McCollough
Journal:  Acad Radiol       Date:  2018-10-02       Impact factor: 3.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.